Ageing populations are experiencing a range of health conditions, with deteriorating joints high on the list. In this special series NutraIngredients looks at the science, supply and regulations of the joint health market.
Aurora Algae – the firm promising to turn up the heat in the algal omega-3 market by producing a concentrated 65% EPA-rich oil on a completely new scale – aims to ship out its first commercial products in the fourth quarter of 2012.
The joint health space is in good shape in most markets globally with (mostly supplement) sales sitting at about $2bn.
In the fourth part of our series on joint health, we look beyond glucosamine and chondroitin to the next generation of joint health ingredients.
In the third part of our series on joint health, we look at the sometimes conflicting but always burgeoning science behind the ingredients.
In the second part of this NutraIngredients focus on joint health, we analyse the elbow work going on in the supply channel.
In the first part of a special edition on joint health, Nutraingredients.com looks at the market for the ingredient that far outpaces the others in the pack - glucosamine.